2021 AHA科学声明：急性心肌梗死合并心源性休克的介入治疗

2021-03-04 美国心脏协会 Circulation . 2021 Mar 4

2021年3月，美国心脏协会（AHA）颁布了急性心肌梗死合并心源性休克的介入治疗科学声明，对当前介入治疗的最佳实践进行了概述，并涉及了患者的综合管理，包括血压管理、抗血小板治疗等。

中文标题：

英文标题：

Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association

发布机构：

美国心脏协会

发布日期：

2021-03-04

简要介绍：

2021年3月，美国心脏协会（AHA）颁布了急性心肌梗死合并心源性休克的介入治疗科学声明，对当前介入治疗的最佳实践进行了概述，并涉及了患者的综合管理，包括血压管理、抗血小板治疗等。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=988f41c002080606, title=2021 AHA科学声明：急性心肌梗死合并心源性休克的介入治疗, enTitle=Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association, guiderFrom=Circulation . 2021 Mar 4, authorId=0, author=, summary=2021年3月，美国心脏协会（AHA）颁布了急性心肌梗死合并心源性休克的介入治疗科学声明，对当前介入治疗的最佳实践进行了概述，并涉及了患者的综合管理，包括血压管理、抗血小板治疗等。, cover=https://img.medsci.cn/2021410/1618058561879_2020535.jpg, journalId=0, articlesId=null, associationId=60, associationName=美国心脏协会, associationIntro=美国心脏协会（AHA，American Heart Association）是心脏病学领域比较正要的学会之一，致力于心脏病和卒中的预防与治疗，提供相关继续教育、流行病学年度报告。每年举办学术年会报道中的的临床试验结果等，有官方杂志《美国心脏协会杂志》，提供心血管疾病和卒中相关的指南及专家共识，更新的比较快。, copyright=0, guiderPublishedTime=Thu Mar 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年3月，美国心脏协会（AHA）颁布了急性心肌梗死合并心源性休克的介入治疗科学声明，对当前介入治疗的最佳实践进行了概述，并涉及了患者的综合管理，包括血压管理、抗血小板治疗等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;"> </div>, tagList=[TagDto(tagId=678, tagName=急性心肌梗死)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=678, guiderKeyword=急性心肌梗死, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4515, appHits=406, showAppHits=0, pcHits=1132, showPcHits=4107, likes=4, shares=29, comments=17, approvalStatus=1, publishedTime=Sat Apr 10 21:09:10 CST 2021, publishedTimeString=2021-03-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Apr 10 20:42:46 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:38:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 AHA科学声明：急性心肌梗死合并心源性休克的介入治疗.pdf)])

2021 AHA科学声明：急性心肌梗死合并心源性休克的介入治疗.pdf

下载请点击：

评论区 (14)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
2022-05-14 ms2000001729622810

不错的资料

50 0
[GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
2021-09-28 1477308bm10(暂无昵称)

想要学习

82 0
[GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
2021-09-14 一生何求9527

收获巨大

71 0
[GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
2021-08-23 ms1000002003099783

挺好

84 0
[GetPortalCommentsPageByObjectIdResponse(id=1219515, encodeId=731012195153b, content=不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a65a5446189, createdName=ms2000001729622810, createdTime=Sat May 14 08:52:50 CST 2022, time=2022-05-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055866, encodeId=53a810558660d, content=想要学习 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201109/c4a2f0cf055e4bc8bb3970902a633d4c/150e8482ab7446959f44f9c8dd6e022c.jpg, createdBy=19d75217845, createdName=1477308bm10(暂无昵称), createdTime=Tue Sep 28 23:33:52 CST 2021, time=2021-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051285, encodeId=05e11051285c7, content=收获巨大, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10465605922, createdName=一生何求9527, createdTime=Tue Sep 14 21:59:58 CST 2021, time=2021-09-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1010563, encodeId=cc311010563d1, content=挺好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be385581756, createdName=ms1000002003099783, createdTime=Mon Aug 23 11:12:27 CST 2021, time=2021-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1004237, encodeId=7155100423e42, content=非常不错的资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=58903970805, createdName=1397ad3dm59暂无昵称, createdTime=Sat Jul 31 15:54:30 CST 2021, time=2021-07-31, status=1, ipAttribution=)]
2021-07-31 1397ad3dm59暂无昵称

非常不错的资料

81 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

心血管指南

2021 AHA科学声明：急性心肌梗死合并心源性休克的介入治疗

相关指南

拓展阅读

科室

工具

服务